Portal de Periódicos da CAPES

Use of Procalcitonin in Patients With Various Degrees of Chronic Kidney Disease Including Renal Replacement Therapy

2014; Oxford University Press; Volume: 59; Issue: 12 Linguagem: Inglês

10.1093/cid/ciu732

1537-6591

E. E. Grace, Robin Turner,

Dialysis and Renal Disease Management

This review provides guidance for the use of procalcitonin as a biological marker for infection in patients with acute and chronic renal failure, including patients on various forms of renal replacement therapy, in an effort to safely decrease antibiotic use.